Search Results - Thomas Capozza
- Showing 1 - 1 results of 1
-
1
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INT‐787, a Novel Farnesoid X Receptor Agonist, in Healthy Volunteers: A Phase 1 Trial Autoría: Thomas Capozza, Jennifer Burkey, Jeroen Van De Wetering, Reinhold Kerb, Jennifer Callahan, Ludmila Kryzhanovskaya, Mary Erickson
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso